In an effort to contain health care costs, the Centers for Medicare & Medicaid Services (CMS) began requiring hospitals to disclose prices negotiated with insurers on January 1, 2021. Existing analysis of transparency efforts via chargemaster lists has shown substantial variation in prices and limited utility when comparing prices for oncological services. READ MORE